Advisory Services Network’s Cymabay Therapeutics CBAY Stock Holding History

Advisory Services Network’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-41	Closed	-$968	–	3864
2023 Q4	$968	Buy	+41	New	+$730	﹤0.01%	3538
2020 Q4	–	Sell	-40	Closed	-$303	–	3812
2020 Q3	$0	Buy	+40	New	+$214	﹤0.01%	3679

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Advisory Services Network's CBAY Position: Q1 2024 in Review

Advisory Services Network sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 41 shares — an estimated $968 sold.

Advisory Services Network first reported a position in CBAY in Q3 2020 and held it in 2 quarters. The position peaked at $968 in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Advisory Services Network reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 41 Cymabay Therapeutics shares in Q1 2024, an estimated $968.
Advisory Services Network first reported a position in Cymabay Therapeutics in Q3 2020 and held it in 2 quarters.
Advisory Services Network's Cymabay Therapeutics position peaked at $968 in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.